Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Pei-En Jian"'
Autor:
Wei Wei, Pei-En Jian, Shao-Hua Li, Zhi-Xing Guo, Yong-Fa Zhang, Yi-Hong Ling, Xiao-Jun Lin, Li Xu, Ming Shi, Lie Zheng, Min-Shan Chen, Rong-Ping Guo
Publikováno v:
Cancer Communications, Vol 38, Iss 1, Pp 1-12 (2018)
Abstract Background The optimal strategy for adjuvant therapy after curative resection for hepatocellular carcinoma (HCC) patients with solitary tumor and microvascular invasion (MVI) is controversial. This trial evaluated the efficacy and safety of
Externí odkaz:
https://doaj.org/article/c9341ed7845c463cabb27f4eb90a21af
Autor:
Wei Wei, Yong Fa Zhang, Ming Shi, Pei En Jian, Li Xu, Jia Hong Wang, Cheng Zuo Xiao, Rong Ping Guo, Xiao Ping Zhong
Publikováno v:
OncoTargets and therapy
Yong-Fa Zhang,1–3,* Wei Wei,1–3,* Jia-Hong Wang,1–3,* Li Xu,1–3 Pei-En Jian,1–3 Cheng-Zuo Xiao,4 Xiao-Ping Zhong,1–3 Ming Shi,1–3 Rong-Ping Guo1–3 1Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, 2State Key
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b56ba2f85a7d925f9b2cb868ee9198e2
https://doi.org/10.2147/ott.s106659
https://doi.org/10.2147/ott.s106659
Autor:
Yong Le, Min Ke He, Pei En Jian, Zi‑Shan Yu, Li‑Juan Wang, Ming Shi, Han Yue OuYang, Yong Fa Zhang
Publikováno v:
Oncology Letters.
Hepatocellular carcinoma (HCC) is among the most fatal types of cancer worldwide due to its high rates of recurrence and metastasis. The molecular processes involved in HCC progression require further investigation to identify biomarkers for use in d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28705948d6b5a4bcb86d3c44204416eb
https://doi.org/10.3892/ol.2018.8642
https://doi.org/10.3892/ol.2018.8642
Autor:
Min-Ke, He, Yong, Le, Yong-Fa, Zhang, Han-Yue, Ouyang, Pei-En, Jian, Zi-Shan, Yu, Li-Juan, Wang, Ming, Shi
Publikováno v:
Oncology letters. 16(1)
Hepatocellular carcinoma (HCC) is among the most fatal types of cancer worldwide due to its high rates of recurrence and metastasis. The molecular processes involved in HCC progression require further investigation to identify biomarkers for use in d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4ea97e48f58b429b37e7d975949a0c95
https://pubmed.ncbi.nlm.nih.gov/29928435
https://pubmed.ncbi.nlm.nih.gov/29928435
Autor:
Ming Shi, Yi Hong Ling, Zhi Xing Guo, Pei En Jian, Xiaojun Lin, Lie Zheng, Wei Wei, Yong Fa Zhang, Minshan Chen, Li Xu, Rong Ping Guo, Shao-Hua Li
Publikováno v:
Cancer Communications, Vol 38, Iss 1, Pp 1-12 (2018)
Cancer Communications
Cancer Communications
Background The optimal strategy for adjuvant therapy after curative resection for hepatocellular carcinoma (HCC) patients with solitary tumor and microvascular invasion (MVI) is controversial. This trial evaluated the efficacy and safety of adjuvant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8779ffb540abc4afb0ccb467bb55413
https://doi.org/10.1186/s40880-018-0331-y
https://doi.org/10.1186/s40880-018-0331-y
Autor:
Pei En Jian, Jia Hong Wang, Yong Fa Zhang, Rong Ping Guo, Ming Shi, Xiao Liang Wu, Jing Xu, Wei Wei, Zhi Xing Guo, Cheng Zuo Xiao
Publikováno v:
Oncotarget
// Jia-hong Wang 1, * , Wei Wei 1, * , Jing Xu 2 , Zhi-xing Guo 3 , Cheng-zuo Xiao 1 , Yong-fa Zhang 1 , Pei-en Jian 1 , Xiao-liang Wu 2 , Ming Shi 1 , Rong-ping Guo 1 1 Department of Hepatobilliary Oncology, Sun Yat-sen University Cancer Center, Sta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0660aa50b9a52ccb985f771eaf95519
https://pubmed.ncbi.nlm.nih.gov/26375669
https://pubmed.ncbi.nlm.nih.gov/26375669
Autor:
Shao Hua Li, Ming Shi, Jia Hong Wang, Rong Ping Guo, Wei Wei, Xiao Ping Zhong, Yong Fa Zhang, Yi Hong Ling, Xiao Liang Wu, Pei En Jian, Minshan Chen
Publikováno v:
Cell Death & Disease
We have previously reported that Cezanne could be a prognostic biomarker for survival in hepatocellular carcinoma (HCC) patients. However, the role of Cezanne genes in HCC cells and its response to postoperative adjuvant transcatheter arterial chemoe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aa9ac4e7dcd7794b00a0451c65c4a02
https://doi.org/10.1038/cddis.2017.428
https://doi.org/10.1038/cddis.2017.428